Dose Escalated Adaptive RadioTherapy in Definitive Chemo-radiotherapy for Esophageal Cancer (DART)
Dose Escalated Adaptive RadioTherapy - a Randomised Phase II Study of Definitive Chemo-radiotherapy in Locally Advanced Esophageal Cancer
Sponsor: Aarhus University Hospital Skejby
Terminated
New data show no effect of dose escalation and also poor recruitment
Other terminated trials from Aarhus University Hospital Skejby
A NA clinical study on Esophageal Cancer, this trial is terminated or withdrawn. The trial is conducted by Aarhus University Hospital Skejby and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Oct 2019 — Feb 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital Skejby
- Odense University Hospital
- Rigshospitalet, Denmark
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .